Stem cell applications in military medicine

Stem Cell Research and Therapy

Volumn 2, Issue 5, 2011, Pages

  Christopherson, Gregory T ^a   Nesti, Leon J ^a,b  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b Department of Orthopaedic Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSENSOR; BLAST INJURY; BRAIN TISSUE; CELL GROWTH; CELL TYPE; COGNITION; ERYTHROCYTE; HEART INJURY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOBIOLOGY; KIDNEY INJURY; LUNG INJURY; LUNG PARENCHYMA; MESENCHYMAL STEM CELL; MILITARY MEDICINE; NERVOUS SYSTEM INJURY; NEURAL STEM CELL; OCCUPATIONAL HEALTH; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SKIN INJURY; SOFT TISSUE INJURY; STEM CELL; THROMBOCYTE; TISSUE ENGINEERING; TISSUE MICROARRAY; CYTOLOGY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INJURY; STEM CELL TRANSPLANTATION;

HUMANS; IMMUNOMODULATION; IMMUNOSUPPRESSION; MILITARY MEDICINE; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; STEM CELLS; WOUNDS AND INJURIES;

EID: 80054967633     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt81     Document Type: Review

References (109)

1. Adult stem cell treatments for diseases? Smith S, Neaves W, Teitelbaum S, Science 2006 313 439 16840663 (Pubitemid 44148429)
2. Cell therapy for secondary osteonecrosis of the femoral condyles using the Cellect DBM System: a preliminary report. Lee K, Goodman SB, J Arthroplasty 2009 24 43 48 10.1016/j.arth.2008.01.133 18534437
3. Mesenchymal stem cell allograft in revision foot and ankle surgery: a clinical and radiographic analysis. Rush SM, Hamilton GA, Ackerson LM, J Foot Ankle Surg 2009 48 163 169 10.1053/j.jfas.2008.12.008 19232968
4. Stem cells derived from cord blood in transplantation and regenerative medicine. Reimann V, Creutzig U, Kögler G, Dtsch Arztebl Int 2009 106 831 836 20049094
5. Regenerative Medicine. Department of Health and Human Services, NIH 2006 http://stemcells.nih.gov/staticresources/info/scireport/pdfs/ regenerative-medicine-2006.pdf
6. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Takahashi K, Yamanaka S, Cell 2006 126 663 676 10.1016/j.cell.2006.07.024 16904174 (Pubitemid 44233629)
7. Incidence of primary blast injury in US military overseas contingency operations: a retrospective study. Ritenour AE, Blackbourne LH, Kelly JF, McLaughlin DF, Pearse LA, Holcomb JB, Wade CE, Ann Surg 2010 251 1140 1144 10.1097/SLA.0b013e3181e01270 20485126
8. Injuries from explosions: physics, biophysics, pathology, and required research focus. Champion HR, Holcomb JB, Young LA, J Trauma 2009 66 1468 1477 discussion 1477 10.1097/TA.0b013e3181a27e7f 19430256
9. Global primary blast injury: a rat model. Irwin RJ, Lerner MR, Bealer JF, Lightfoot SA, Brackett DJ, Tuggle DW, J Okla State Med Assoc 1998 91 387 392 9793276
10. Blast injury research models. Kirkman E, Watts S, Cooper G, Philos Trans R Soc Lond B Biol Sci 2011 366 144 159 10.1098/rstb.2010.0240 21149352
11. Stem cells, ageing and the quest for immortality. Rando TA, Nature 2006 441 1080 1086 10.1038/nature04958 16810243 (Pubitemid 43990720)
12. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. Caplan AI, J Cell Physiol 2007 213 341 347 10.1002/jcp.21200 17620285 (Pubitemid 47509711)
13. Assessment and treatment of pain associated with combat-related polytrauma. Clark ME, Scholten JD, Walker RL, Gironda RJ, Pain Med 2009 10 456 469 10.1111/j.1526-4637.2009.00589.x 19416437
14. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Lutolf MP, Hubbell JA, Nat Biotechnol 2005 23 47 55 10.1038/nbt1055 15637621 (Pubitemid 41724624)
15. Complexity in biomaterials for tissue engineering. Place ES, Evans ND, Stevens MM, Nat Mater 2009 8 457 470 10.1038/nmat2441 19458646
16. Current applications and future perspectives of artificial nerve conduits. Jiang X, Lim SH, Mao H-Q, Chew SY, Exp Neurol 2010 223 86 101 10.1016/j.expneurol.2009.09.009 19769967
17. Combat ocular trauma and systemic injury. Weichel ED, Colyer MH, Curr Opin Ophthalmol 2008 19 519 525 10.1097/ICU.0b013e3283140e98 18854697
18. Strategies for retinal repair: cell replacement and regeneration. Lamba DA, Karl MO, Reh TA, Prog Brain Res 2009 175 23 31 19660646
19. Stepwise differentiation of pluripotent stem cells into retinal cells. Osakada F, Ikeda H, Sasai Y, Takahashi M, Nat Protoc 2009 4 811 824 19444239
20. Treatment viability of stem cells in ophthalmology. Jeganathan VSE, Palanisamy M, Curr Opin Ophthalmol 2010 21 213 217 10.1097/ICU.0b013e32833867ad 20393292
21. Hair cell regeneration. Edge AS, Chen ZY, Curr Opin Neurobiol 2008 18 377 382 10.1016/j.conb.2008.10.001 18929656
22. Sensory cell regeneration and stem cells: what we have already achieved in the management of deafness. Vlastarakos PV, Nikolopoulos TP, Tavoulari E, Papacharalambous G, Tzagaroulakis A, Dazert S, Otol Neurotol 2008 29 758 768 10.1097/MAO.0b013e31817fdfad 18665007
23. Can neurosphere production help restore inner ear transduction? Collado MS, Holt JR, Proc Natl Acad Sci USA 2009 106 8 9 10.1073/pnas.0811804106 19118205
24. Gene therapy and stem cell transplantation: strategies for hearing restoration. Kesser BW, Lalwani AK, Adv Otorhinolaryngol 2009 66 64 86 19494573
25. Treatment of upper limb nerve war injuries associated with vascular trauma. Stanec S, Tonkovic I, Stanec Z, Tonkovic D, Dzepina I, Injury 1997 28 463 468 10.1016/S0020-1383(97)00086-7 9509088 (Pubitemid 28014226)
26. Characterization of extremity wounds in Operation Iraqi Freedom and Operation Enduring Freedom. Owens BD, Kragh JF Jr, Macaitis J, Svoboda SJ, Wenke JC, J Orthop Trauma 2007 21 254 257 10.1097/BOT.0b013e31802f78fb 17414553 (Pubitemid 46588274)
27. Promoting axonal myelination for improving neurological recovery in spinal cord injury. Wu B, Ren X, J Neurotrauma 2009 26 1847 1856 10.1089/neu.2008.0551 19785544
28. From the battlefront: peripheral nerve surgery in modern day warfare. Ecklund JM, Ling GS, Neurosurg Clin N Am 2009 20 107 110 vii 10.1016/j.nec.2008.07.022 19064183
29. Stem cells in human neurodegenerative disorders-time for clinical translation? Lindvall O, Kokaia Z, J Clin Invest 2010 120 29 40 10.1172/JCI40543 20051634
30. Remyelination in the CNS: from biology to therapy. Franklin RJM, Ffrench-Constant C, Nat Rev Neurosci 2008 9 839 855 10.1038/nrn2480 18931697
31. Use of stem cells to augment nerve injury repair. Walsh S, Midha R, Neurosurgery 2009 65 80 86 10.1227/01.NEU.0000335651.93926.2F 19927083
32. Stem cell-based therapies for spinal cord injury. Nandoe Tewarie RS, Hurtado A, Bartels RH, Grotenhuis A, Oudega M, J Spinal Cord Med 2009 32 105 114 19569457
33. Are induced pluripotent stem cells the future of cell-based regenerative therapies for spinal cord injury? Salewski RP, Eftekharpour E, Fehlings MG, J Cell Physiol 2010 222 515 521 20020443
34. Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells? Ronaghi M, Erceg S, Moreno-Manzano V, Stojkovic M, Stem Cells 2010 28 93 99 19904738
35. Epidemiology of combat wounds in operation iraqi freedom and operation enduring freedom: orthopaedic burden of disease. Belmont PJ, Schoenfeld AJ, Goodman G, J Surg Orthop Adv 2010 19 2 7 20370999
36. Prevention and management of infections associated with combatrelated extremity injuries. Murray CK, Hsu JR, Solomkin JS, Keeling JJ, Andersen RC, Ficke JR, Calhoun JH, J Trauma 2008 64 239 251 10.1097/TA.0b013e318163cd14 18316968 (Pubitemid 351644346)
37. Heterotopic ossification following traumatic brain injury and spinal cord injury. Cipriano CA, Pill SG, Keenan MA, J Am Acad Orthop Surg 2009 17 689 697 19880679
38. Putative heterotopic ossification progenitor cells derived from traumatized muscle. Jackson WM, Aragon AB, Bulken-Hoover JD, Nesti LJ, Tuan RS, J Orthop Res 2009 27 1645 1651 10.1002/jor.20924 19517576
39. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Baksh D, Yao R, Tuan RS, Stem Cells 2007 25 1384 1392 10.1634/stemcells.2006-0709 17332507 (Pubitemid 47106005)
40. Adipose-derived stem cells: isolation, expansion and diff erentiation. Bunnell BA, Flaat M, Gagliardi C, Patel B, Ripoll C, Methods 2008 45 115 120 10.1016/j.ymeth.2008.03.006 18593609 (Pubitemid 351885360)
41. Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue. Nesti LJ, Jackson WM, Shanti RM, Koehler SM, Aragon AB, Bailey JR, Sracic MK, Freedman BA, Giuliani JR, Tuan RS, J Bone Joint Surg 2008 90 2390 2398 10.2106/JBJS.H.00049 18978407
42. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. Qu-Petersen Z, Deasy B, Jankowski R, Ikezawa M, Cummins J, Pruchnic R, Mytinger J, Cao B, Gates C, Wernig A, Huard J, J Cell Biol 2002 157 851 864 10.1083/jcb.200108150 12021255 (Pubitemid 34847822)
43. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. Giordano A, Galderisi U, Marino IR, J Cell Physiol 2007 211 27 35 10.1002/jcp.20959 17226788 (Pubitemid 46363893)
44. Application of mesenchymal stromal cells in urological diseases. Montzka K, Heidenreich A, BJU Int 2010 105 309 312 10.1111/j.1464-410X.2009.09077.x 19912199
45. Cellular strategies for enhancement of fracture repair. Patterson TE, Kumagai K, Griffith L, Muschler GF, J Bone Joint Surg Am 2008 90 Suppl 1 111 119 http://www.ncbi.nlm.nih.gov/pubmed/18292365 18676945 (Pubitemid 351329129)
46. Mesenchymal cells for skeletal tissue engineering. Slater BJ, Kwan MD, Gupta DM, Panetta NJ, Longaker MT, Expert Opin Biol Ther 2008 8 885 893 10.1517/14712598.8.7.885 18549320 (Pubitemid 352007001)
47. Stem cells for the treatment of skeletal muscle injury. Quintero AJ, Wright VJ, Fu FH, Huard J, Clin Sports Med 2009 28 1 11 10.1016/j.csm.2008.08. 009 19064161
48. Adipose-derived stem cells: characterization and current application in orthopaedic tissue repair. Tapp H, Hanley EN, Patt JC, Gruber HE, Exp Biol Med 2009 234 1 9 10.3181/0805-MR-170
49. Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells. Jackson WM, Nesti LJ, Tuan RS, Expert Opin Biol Ther 2010 10 505 517 10.1517/14712591003610606 20218920
50. Technology Insight: adult stem cells in cartilage regeneration and tissue engineering. Chen FH, Rousche KT, Tuan RS, Nat Clin Pract Rheumatol 2006 2 373 382 10.1038/ncprheum0216 16932723
51. Cell-free and cell-based approaches for bone regeneration. Bueno EM, Glowacki J, Nat Rev Rheumatol 2009 5 685 697 10.1038/nrrheum.2009.228 19901916
52. Cardiopulmonary physiology of primary blast injury. Irwin RJ, Lerner MR, Bealer JF, Brackett DJ, Tuggle DW, J Trauma 1997 43 650 655 10.1097/00005373- 199710000-00015 9356063 (Pubitemid 27467688)
53. Blast lung injury. Sasser SM, Sattin RW, Hunt RC, Krohmer J, Prehosp Emerg Care 2006 10 165 172 10.1080/10903120500540912 16531371
54. Blast injuries. Wolf SJ, Bebarta VS, Bonnett CJ, Pons PT, Cantrill SV, Lancet 2009 374 405 415 10.1016/S0140-6736(09)60257-9 19631372
55. Stem cells and lung cancer: future therapeutic targets? Alison MR, Lebrenne AC, Islam S, Expert Opin Biol Ther 2009 9 1127 1141 10.1517/14712590903103803 19653862
56. Bioengineered lung epithelium: implications for basic and applied studies in lung tissue regeneration. Stripp BR, Reynolds SD, Am J Respir Cell Mol Biol 2005 32 85 86 15657173 (Pubitemid 40189688)
57. Innovative approaches to the therapy of fibrosis. de Andrade JA, Thannickal VJ, Curr Opin Rheumatol 2009 21 649 655 10.1097/BOR.0b013e328330da9b 19667993
58. Potential application of mesenchymal stem cells in acute lung injury. Lee JW, Gupta N, Serikov V, Matthay MA, Expert Opin Biol Ther 2009 9 1259 1270 10.1517/14712590903213651 19691441
59. Bronchiolar progenitor cells. Chen H, Matsumoto K, Stripp BR, Proc Am Thorac Soc 2009 6 602 606 10.1513/pats.200907-078RM 19934356
60. Vascular trauma in high-velocity gunshot wounds and shrapnel-blast injuries in Israel. Wolf YG, Rivkind A, Surg Clin North Am 2002 82 237 244 10.1016/S0039-6109(03)00152-X 11905949 (Pubitemid 34226503)
61. Stem cell therapy for vascular disease. Adams B, Xiao Q, Xu Q, Trends Cardiovasc Med 2007 17 246 251 10.1016/j.tcm.2007.08.005 17936207 (Pubitemid 47532730)
62. Mesenchymal stem cells and cardiac repair. Nesselmann C, Ma N, Bieback K, Wagner W, Ho A, Konttinen YT, Zhang H, Hinescu ME, Steinhoff G, J Cell Mol Med 2008 12 1795 1810 10.1111/j.1582-4934.2008.00457.x 18684237
63. Therapeutic potential of adipose-derived stem cells in vascular growth and tissue repair. Hong SJ, Traktuev DO, March KL, Curr Opin Organ Transplant 2010 15 86 91 10.1097/MOT.0b013e328334f074 19949335
64. Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Ferreira LS, Gerecht S, Shieh HF, Watson N, Rupnick MA, Dallabrida SM, Vunjak- Novakovic G, Langer R, Circ Res 2007 101 286 294 10.1161/CIRCRESAHA.107. 150201 17569886 (Pubitemid 47344078)
65. Vascular regeneration: engineering the stem cell microenvironment. Sun G, Gerecht S, Regen Med 2009 4 435 447 10.2217/rme.09.1 19438318
66. Stem cell therapy for cardiac repair: benefits and barriers. Joggerst SJ, Hatzopoulos AK, Expert Rev Mol Med 2009 11 20 19586557
67. Cardiac cell repair therapy: a clinical perspective. Gersh BJ, Simari RD, Behfar A, Terzic CM, Terzic A, Mayo Clin Proc 2009 84 876 892 10.4065/84.10.876 19797777
68. Stem cells and their applications in skin-cell therapy. Shi C, Zhu Y, Su Y, Cheng T, Trends Biotechnol 2006 24 48 52 10.1016/j.tibtech.2005.11.003 16298447 (Pubitemid 43017750)
69. Stem cells and tissue-engineered skin. Charruyer A, Ghadially R, Skin Pharmacol Physiol 2009 22 55 62 10.1159/000178864 19188753
70. Coexistence of quiescent and active adult stem cells in mammals. Li LH, Clevers H, Science 2010 327 542 545 10.1126/science.1180794 20110496
71. A review of tissue-engineered skin bioconstructs available for skin reconstruction. Shevchenko RV, James SL, James SE, J R Soc Interface 2010 7 229 258 10.1098/rsif.2009.0403 19864266
72. Novel therapies for scar reduction and regenerative healing of skin wounds. Rhett JM, Ghatnekar GS, Palatinus JA, O'Quinn M, Yost MJ, Gourdie RG, Trends Biotechnol 2008 26 173 180 10.1016/j.tibtech.2007.12.007 18295916
73. Heterotopic Ossification Following Musculoskeletal Trauma: Modeling Stem and Progenitor Cells in Their Microenvironment. Ji Y, Christopherson GT, Kluk M, Amrani O, Jackson WM, Nesti LJ, Human Cell Transformation: Role of Stem Cells and the Microenvironment, Advances in Experimental Medicine and Biology New York: Springer, Rhim JS, Kremer R, 1 2011 720 39 50
74. Fetal skin wound healing. Buchanan EP, Longaker MT, Lorenz HP, Adv Clin Chem 2009 48 137 161 19803418
75. Adult and fetal wound healing. Hantash BM, Zhao L, Knowles JA, Lorenz HP, Front Biosci 2008 13 51 61 10.2741/2559 17981527 (Pubitemid 351594762)
76. Renal replacement therapy in support of combat operations. Chung KK, Perkins RM, Oliver JD, Crit Care Med 2008 36 365 369 10.1097/CCM. 0b013e31817e302a 18594264
77. Stem cell therapy for the kidney? Zubko R, Frishman W, Am J Ther 2009 16 247 256 10.1097/MJT.0b013e3181800591 19092639
78. Why are MSCs therapeutic? New data: new insight. Caplan AI, J Pathol 2009 217 318 324 10.1002/path.2469 19023885
79. Stem cell paracrine actions and tissue regeneration. Baraniak PR, McDevitt TC, Regen Med 2010 5 121 143 10.2217/rme.09.74 20017699
80. DARPA Blood Pharming Strategic Thrust. http://www.darpa.mil/Our-Work/DSO/ Programs/Blood-Pharming.aspx
81. Blood cell manufacture: current methods and future challenges. Timmins NE, Nielsen LK, Trends Biotechnol 2009 27 415 422 10.1016/j.tibtech.2009.03.008 19500866
82. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Lee JW, Fang X, Gupta N, Serikov V, Matthay MA, Proc Natl Acad Sci USA 2009 106 16357 16362 10.1073/pnas.0907996106 19721001
83. Novel therapeutic targets for prevention and therapy of sepsis associated acute kidney injury. Pelte CH, Chawla LS, Curr Drug Targets 2009 10 1205 1211 10.2174/138945009789753219 19715536
84. Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation. Bielorai B, Toren A, Wolach B, Mandel M, Golan H, Neumann Y, Kaplinisky C, Weintraub M, Keller N, Amariglio N, Paswell J, Rechavi G, Bone Marrow Transplant 2000 26 1025 1028 10.1038/sj.bmt.1702651 11100285
85. Angiogenic gene therapy as a potential therapeutic agent in chronic osteomyelitis. Ross JJ, Med Hypotheses 2006 67 161 163 10.1016/j.mehy.2006.01. 022 16520007
86. In vitro evaluation of a fibrin gel antibiotic delivery system containing mesenchymal stem cells and vancomycin alginate beads for treating bone infections and facilitating bone formation. Hou T, Xu J, Li Q, Feng J, Zen L, Tissue Eng Part A 2008 141 14 1173 1182 (Pubitemid 351931497)
87. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Kode JA, Mukherjee S, Joglekar MV, Hardikar AA, Cytotherapy 2009 11 377 391 10.1080/14653240903080367 19568970
88. Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update. Seggewiss R, Einsele H, Blood 2010 115 3861 3868 10.1182/blood-2009-12-234096 20215642
89. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Shi Y, Hu G, Su J, Li W, Chen Q, Shou P, Xu C, Chen X, Huang Y, Zhu Z, Huang X, Han X, Xie N, Ren G, Cell Res 2010 20 510 518 10.1038/cr.2010.44 20368733
90. Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool. García-Castro J, Trigueros C, Madrenas J, Pérez-Simán JA, Rodriguez R, Menendez P, J Cell Mol Med 2008 12 2552 2565 10.1111/j.1582-4934.2008.00516.x 19210755
91. Traumatic brain injury and vestibular pathology as a comorbidity after blast exposure. Scherer MR, Schubert MC, Phys Ther 2009 89 980 992 10.2522/ptj.20080353 19628578
92. Suicidal behavior after a traumatic event. Krysinska K, Lester D, Martin G, J Trauma Nurs 2009 16 103 110 19543020
93. Explosive blast neurotrauma. Ling G, Bandak F, Armonda R, Grant G, Ecklund J, J Neurotrauma 2009 26 815 825 10.1089/neu.2007.0484 19397423
94. Transient suppression of progenitor cell proliferation through NMDA receptors in hippocampal dentate gyrus of mice with traumatic stress experience. Tamaki K, Yamada K, Nakamichi N, Taniura H, Yoneda Y, J Neurochem 2008 105 1642 1655 10.1111/j.1471-4159.2008.05253.x 18221371 (Pubitemid 351678485)
95. Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: Implications for depression and antidepressant action. Lucassen PJ, Meerlo P, Naylor AS, van Dam AM, Dayer AG, Fuchs E, Oomen CA, Czéh B, Eur Neuropsychopharmacol 2010 20 1 17 10.1016/j.euroneuro.2009. 08.003 19748235
96. Adult neurogenesis, mental health, and mental illness: hope or hype? Eisch AJ, Cameron HA, Encinas JM, Meltzer LA, Ming G-L, Overstreet-Wadiche LS, J Neurosci 2008 28 11785 11791 10.1523/JNEUROSCI.3798-08.2008 19005040
97. A multi-compartment cell repopulation model allowing for inter-compartmental migration following radiation exposure, applied to leukaemia. Little MP, J Theor Biol 2007 245 83 97 10.1016/j.jtbi.2006.09.026 17092522 (Pubitemid 46215680)
98. Ocular injuries following sulfur mustard exposure - pathological mechanism and potential therapy. Kadar T, Dachir S, Cohen L, Sahar R, Fishbine E, Cohen M, Turetz J, Gutman H, Buch H, Brandeis R, Horwitz V, Solomon A, Amir A, Toxicology 2009 263 59 69 10.1016/j.tox.2008.10.026 19061933
99. Microvesicating effects of sulfur mustard on an in vitro human skin model. Hayden PJ, Petrali JP, Stolper G, Hamilton TA, Jackson GR, Wertz PW, Ito S, Smith WJ, Klausner M, Toxicol In Vitro 2009 23 1396 1405 10.1016/j.tiv.2009. 07.021 19619636
100. Effect of soman poisoning on populations of bone marrow and peripheral blood cells in mice. Collombet J-M, Mourcin F, Grenier N, Four E, Masqueliez C, Baubichon D, Lallement G, Hérodin F, Neurotoxicology 2005 26 89 98 10.1016/j.neuro.2004.07.002 15527876 (Pubitemid 39440968)
101. A B cell-based sensor for rapid identification of pathogens. Rider TH, Petrovick MS, Nargi FE, Harper JD, Schwoebel ED, Mathews RH, Blanchard DJ, Bortolin LT, Young AM, Chen J, Hollis MA, Science 2003 301 213 215 10.1126/science.1084920 12855808 (Pubitemid 36858474)
102. Development and application of cell-based biosensors. Pancrazio JJ, Whelan JP, Borkholder DA, Ma W, Stenger DA, Ann Biomed Eng 1999 27 697 711 10625143 (Pubitemid 129583988)
103. Stem cells in drug discovery, tissue engineering, and regenerative medicine: emerging opportunities and challenges. Nirmalanandhan VS, Sittampalam GS, J Biomol Screen 2009 14 7 755 768 10.1177/1087057109336591 19675315
104. Stem cell biobanks. Bardelli S, J Cardiovasc Transl Res 2010 3 128 134 10.1007/s12265-009-9143-4 20560026
105. Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. ISCBI, Stem Cell Rev 2009 5 301 314 20016957
106. Mesenchymal progenitor cells derived from traumatized human muscle. Jackson WM, Aragon AB, Djouad F, Song Y, Koehler SM, Nesti LJ, Tuan RS, J Tissue Eng Regen Med 2009 3 129 138 10.1002/term.149 19170141
107. Extrapolation of battlefield resuscitative care to the civilian setting. D'Alleyrand JC, Dutton RP, Pollak AN, J Surg Orthop Adv 2010 19 62 69 20371009
108. Historical perspective: neurological advances from studies of war injuries and illnesses. Lanska DJ, Ann Neurol 2009 66 444 459 10.1002/ana.21822 19847911
109. NIH Stem Cell Information. http://stemcells.nih.gov/info/